Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Repealing the Job-Killing Health Care Law Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Repealing the Job-Killing Health Care Law Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CLASS ACTION FAIRNESS COALITION via CONSTANTINE CANNON, LLP
2017 · fourth_quarter · Q4
Class action legislation.
Filing targets: SENATE
PROFESSIONAL LICENSING COALITION via CONSTANTINE CANNON, LLP
2017 · fourth_quarter · Q4
Source: Senate LDA
| BROOKSIDE CAPITAL PARTNERS/HILLSIDE CAPITAL INCORPORATED | 8 | 2005–2009 |
| PROFESSIONAL LICENSING COALITION | 8 | 2016–2017 |
| CIRCUIT CITY STORES INC | 7 | 2005–2009 |
| GAZELLE, INC. | 4 | 2013–2014 |
| PURDUE PHARMA L.P. | 4 | 2005–2007 |
| CLASS ACTION FAIRNESS COALITION | 3 | 2017 |
| WHOLE FOODS MARKETS, INC. | 3 | 2008–2009 |
| CARDSYSTEMS SOLUTIONS INC | 2 | 2005 |
| WALGREEN CO | 2 | 2012 |
| CARMAX INC | 1 | 2005 |
| QWEST COMMUNICATIONS INTL | 1 | 2005 |
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Repealing the Job-Killing Health Care Law Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation H.R. 2 -- healthcare reform bill repeal PDUFA reauthorization; Life sciences research tax credit legislation Orphan drug issues
Repealing the Job-Killing Health Care Law Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation H.R. 2 -- healthcare reform bill repeal PDUFA reauthorization; Life sciences research tax credit legislation Orphan drug issues
Life Sciences Jobs and Investment Act of 2011
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Life Sciences Jobs and Investment Act of 2011
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Preserving Access to Orphan Drugs Act of 2011
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Preserving Access to Orphan Drugs Act of 2011
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
340B Program Improvement Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
340B Program Improvement Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Pathway for Biosimilars Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Pathway for Biosimilars Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Protecting Consumer Access to Generic Drugs Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Protecting Consumer Access to Generic Drugs Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Protecting Consumer Access to Generic Drugs Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 - patent settlements.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
America's Affordable Health Choices Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
America's Affordable Health Choices Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Health Insurance Industry Antitrust Enforcement Act of 2009
Client: INSURANCE SERVICES OFFICE (ISO) · Firm: CONSTANTINE CANNON, LLP
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681.
Health Insurance Industry Antitrust Enforcement Act of 2009
Client: INSURANCE SERVICES OFFICE (ISO) · Firm: CONSTANTINE CANNON, LLP
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681. Financial reform legislation, H.R. 4173.
Stop Oxy Abuse Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Physician Payment and Therapy Relief Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Physician Payment and Therapy Relief Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Physician Payment and Therapy Relief Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Diesel Emissions Reduction Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Life Sciences Jobs and Investment Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Life Sciences Jobs and Investment Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Health Insurance Industry Antitrust Enforcement Act of 2009
Client: INSURANCE SERVICES OFFICE (ISO) · Firm: CONSTANTINE CANNON, LLP
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681. Financial reform legislation, H.R. 4173.
Health Insurance Industry Antitrust Enforcement Act of 2009
Client: INSURANCE SERVICES OFFICE (ISO) · Firm: CONSTANTINE CANNON, LLP
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681.
America's Healthy Future Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
America's Healthy Future Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Physician Payments Sunshine Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Physician Payments Sunshine Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Secure and Responsible Drug Disposal Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Preserve Access to Affordable Generics Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Preserve Access to Affordable Generics Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 - patent settlements.
Preserve Access to Affordable Generics Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Preserve Access to Affordable Generics Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Life Sciences Jobs and Investment Act of 2010
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
American Middle Class Tax (AMT) Relief Act of 2007
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Superfund Polluter Pays Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Superfund Polluter Pays Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Overseas Voting Education and Reform, Safeguarding Every American's Vote Act
Client: INSURANCE SERVICES OFFICE (ISO) · Firm: CONSTANTINE CANNON, LLP
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681. Financial reform legislation, H.R. 4173.
Overseas Voting Education and Reform, Safeguarding Every American's Vote Act
Client: RETAIL INDUSTRY LEADERS ASSOCIATION · Firm: CONSTANTINE CANNON, LLP
Issues relating to payment systems. Financial reform legislation, H.R. 4173.
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
To suspend temporarily the duty on 1-Amino-2,6-dimethylbenzene.
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; H.R. 3200 - health care reform; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform); Anti-counterfeiting legislation concerning drugs (pedigree); and S. 301 - physicians payments.
Safe Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree)
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 515, H.R. 1260 - patent reform S. 369, H.R. 1706 - patent settlements
Patent Reform Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 515, H.R. 1260 - patent reform S. 369, H.R. 1706 - patent settlements
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree)
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation anti-counterfeiting legislation concerning drugs S. 301 - physicians payments
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.
Pharmaceutical Market Access and Drug Safety Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; H.R. 3200 - health care reform; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform); Anti-counterfeiting legislation concerning drugs (pedigree); and S. 301 - physicians payments.
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree)
Secure and Responsible Drug Disposal Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; H.R. 3200 - health care reform; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform); Anti-counterfeiting legislation concerning drugs (pedigree); and S. 301 - physicians payments.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; H.R. 3200 - health care reform; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform); Anti-counterfeiting legislation concerning drugs (pedigree); and S. 301 - physicians payments.
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree)
Promoting Innovation and Access to Life-Saving Medicine Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.
Pathway for Biosimilars Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree)
Pathway for Biosimilars Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.
Pathway for Biosimilars Act
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 525, H.R. 1298 - drug reimportation; H.R. 3200 - health care reform; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform); Anti-counterfeiting legislation concerning drugs (pedigree); and S. 301 - physicians payments.
Protecting Consumer Access to Generic Drugs Act of 2009
Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) · Firm: CONSTANTINE CANNON, LLP
S. 515, H.R. 1260 - patent reform S. 369, H.R. 1706 - patent settlements
Antitrust liability issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLASS ACTION FAIRNESS COALITION via CONSTANTINE CANNON, LLP
2017 · third_quarter · Q3
Class action legislation.
Filing targets: SENATE
PROFESSIONAL LICENSING COALITION via CONSTANTINE CANNON, LLP
2017 · third_quarter · Q3
Antitrust liability issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLASS ACTION FAIRNESS COALITION via CONSTANTINE CANNON, LLP
2017 · third_quarter · RR
Class action legislation.
PROFESSIONAL LICENSING COALITION via CONSTANTINE CANNON, LLP
2017 · second_quarter · Q2
Antitrust liability issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL LICENSING COALITION via CONSTANTINE CANNON, LLP
2017 · first_quarter · Q1
Antitrust liability issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL LICENSING COALITION via CONSTANTINE CANNON, LLP
2016 · fourth_quarter · Q4
Antitrust liability issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL LICENSING COALITION via CONSTANTINE CANNON, LLP
2016 · third_quarter · Q3
Antitrust liability issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL LICENSING COALITION via CONSTANTINE CANNON, LLP
2016 · second_quarter · 2A
Antitrust liability issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROFESSIONAL LICENSING COALITION via CONSTANTINE CANNON, LLP
2016 · second_quarter · RR
Antitrust liability issues.
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2015 · first_quarter · Q1
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2014 · fourth_quarter · Q4
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2014 · third_quarter · Q3
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2014 · second_quarter · Q2
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GAZELLE, INC. via CONSTANTINE CANNON, LLP
2014 · second_quarter · Q2
Competitive Secondary Markets for Eligible Cellphones
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
GAZELLE, INC. via CONSTANTINE CANNON, LLP
2014 · first_quarter · Q1
Competitive Secondary Markets for Eligible Cellphones
Filing targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2014 · first_quarter · Q1
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2013 · fourth_quarter · Q4
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GAZELLE, INC. via CONSTANTINE CANNON, LLP
2013 · fourth_quarter · Q4
Competitive Secondary Markets for Eligible Cellphones
Filing targets: Federal Communications Commission (FCC), SENATE
GAZELLE, INC. via CONSTANTINE CANNON, LLP
2013 · fourth_quarter · RR
Competitive Secondary Markets for Eligible Cellphones
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2013 · third_quarter · Q3
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2013 · second_quarter · Q2
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2013 · first_quarter · Q1
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2012 · fourth_quarter · Q4
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2012 · third_quarter · Q3
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2012 · second_quarter · Q2
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2012 · first_quarter · Q1
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO. via CONSTANTINE CANNON, LLP
2012 · first_quarter · Q1
Issues relating to the Express Scripts/Medco Health Solutions merger.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO. via CONSTANTINE CANNON, LLP
2012 · first_quarter · RR
Issues relating to the Express Scripts/Medco Health Solutions merger
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2011 · fourth_quarter · Q4
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2011 · fourth_quarter · Q4
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
S. 27 -- patent settlements H.R. 1249, S. 23 -- patent reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2011 · third_quarter · Q3
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
S. 27 -- patent settlements H.R. 1249, S. 23 -- patent reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2011 · third_quarter · 3A
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2011 · third_quarter · Q3
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2011 · second_quarter · Q2
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2011 · second_quarter · Q2
S. 319 -- drug reimportation H.R. 2 -- healthcare reform bill repeal PDUFA reauthorization; Life sciences research tax credit legislation Orphan drug issues
S. 27 -- patent settlements H.R. 1249, S. 23 -- patent reform
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2011 · second_quarter · Q2
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2011 · first_quarter · Q1
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2011 · first_quarter · Q1
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2011 · first_quarter · Q1
S. 27 -- patent settlements H.R. 1249, S. 23 -- patent reform
S. 319 -- drug reimportation H.R. 2 -- healthcare reform bill repeal PDUFA reauthorization; Life sciences research tax credit legislation Orphan drug issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2010 · fourth_quarter · Q4
Issues relating to payment systems.
Filing targets: SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2010 · fourth_quarter · Q4
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2010 · fourth_quarter · Q4
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2010 · third_quarter · Q3
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
Filing targets: SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2010 · third_quarter · Q3
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336, H.R. 5809, S. 3397 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165 - Life sciences research tax credit legislation H.R. 6165 - Life Sciences research tax credit legislation.
Filing targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
NEW YORK PRIVATE BANK & TRUST CORPORATION/EMIGRANT BANK via CONSTANTINE CANNON, LLP
2010 · third_quarter · RR
Financial reform legislation and related regulatory issues.
Financial reform legislation and related regulatory issues.
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2010 · second_quarter · Q2
Issues relating to payment systems. Financial reform legislation, H.R. 4173.
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2010 · second_quarter · Q2
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681. Financial reform legislation, H.R. 4173.
Filing targets: SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2010 · second_quarter · Q2
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs PDUFA reauthorization H.R. 5712 -- health care technical corrections Life sciences research tax credit legislation
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2010 · first_quarter · Q1
Issues relating to attorney-client privilege.
Issues regarding potential changes in the accounting industry.
Filing targets: HOUSE OF REPRESENTATIVES
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2010 · first_quarter · Q1
Issues relating to payment systems.
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2010 · first_quarter · Q1
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2010 · first_quarter · Q1
S. 369, H.R. 1706 - patent settlements.
H.R. 4872, H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree) PDUFA reauthorization H.R. 4956, modify approval of oxycodone
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2009 · fourth_quarter · Q4
Issues relating to payment systems.
BROOKSIDE CAPITAL PARTNERS/HILLSIDE CAPITAL INCORPORATED via CONSTANTINE CANNON, LLP
2009 · fourth_quarter · Q4
Tax Treatment of net operating losses.
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2009 · fourth_quarter · Q4
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2009 · fourth_quarter · Q4
Issues relating to attorney-client privilege.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2009 · fourth_quarter · Q4
S. 369, H.R. 1706 - patent settlements.
H.R. 3200, H.R. 3590, H.R. 3962, S. 1796 - health care reform S. 525, H.R. 1298 - drug reimportation H.R. 3590, S. 1796 - tax on pharmaceutical companies S. 301 - physicians payments H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs Anti-counterfeiting legislation concerning drugs (pedigree)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROOKSIDE CAPITAL PARTNERS/HILLSIDE CAPITAL INCORPORATED via CONSTANTINE CANNON, LLP
2009 · third_quarter · Q3
Pension Funding Legislation
Tax treatment of net operating losses.
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2009 · third_quarter · Q3
S. 369, H.R. 1706 -- patent settlements.
S. 525, H.R. 1298 - drug reimportation; H.R. 3200 - health care reform; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform); Anti-counterfeiting legislation concerning drugs (pedigree); and S. 301 - physicians payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2009 · third_quarter · Q3
Legislation affecting the insurance industry. Legislation to repeal the McCarran-Ferguson Act, H.R. 3596 and S. 1681.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2009 · second_quarter · Q2
S. 515, H.R. 1260 - patent reform S. 369, H.R. 1706 - patent settlements
S. 525, H.R. 1298 - drug reimportation; S. 301 - physicians payments; H.R. 1427, H.R. 1548, S. 726 - biosimilar drugs; H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; Anti-counterfeiting legislation concerning drugs; Health care reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2009 · second_quarter · Q2
Legislation affecting the insurance industry.
Filing targets: HOUSE OF REPRESENTATIVES
BROOKSIDE CAPITAL PARTNERS/HILLSIDE CAPITAL INCORPORATED via CONSTANTINE CANNON, LLP
2009 · second_quarter · Q2
Tax treatment of net operating losses.
Pension Funding Legislation
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2009 · first_quarter · Q1
Issues relating to attorney-client privilege.
Filing targets: HOUSE OF REPRESENTATIVES
CIRCUIT CITY STORES INC via CONSTANTINE CANNON, LLP
2009 · first_quarter · Q1
Bankruptcy reform.
Filing targets: HOUSE OF REPRESENTATIVES
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2009 · first_quarter · Q1
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES
WHOLE FOODS MARKETS, INC. via CONSTANTINE CANNON, LLP
2009 · first_quarter · Q1
Issues affecting merger enforcement policies in industry.
Issues affecting merger enforcement policies in industry.
Filing targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES
BROOKSIDE CAPITAL PARTNERS/HILLSIDE CAPITAL INCORPORATED via CONSTANTINE CANNON, LLP
2009 · first_quarter · Q1
Pension Funding Legislation.
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2009 · first_quarter · Q1
S. 525, H.R. 1298 - drug reimportation anti-counterfeiting legislation concerning drugs S. 301 - physicians payments
S. 515, H.R. 1260 - patent reform S. 369, H.R. 1706 - patent settlements
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WHOLE FOODS MARKETS, INC. via CONSTANTINE CANNON, LLP
2008 · fourth_quarter · Q4
Issues affecting merger enforcement policies in industry.
Issues affecting merger enforcement policies in industry.
Filing targets: HOUSE OF REPRESENTATIVES
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2008 · fourth_quarter · Q4
Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines
Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2008 · fourth_quarter · Q4
Issues relating to payment systems.
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2008 · fourth_quarter · Q4
Legislation affecting the insurance industry.
BROOKSIDE CAPITAL PARTNERS/HILLSIDE CAPITAL INCORPORATED via CONSTANTINE CANNON, LLP
2008 · fourth_quarter · Q4
Pension Funding Legislation.
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2008 · fourth_quarter · Q4
Issues relating to attorney-client privilege.
WHOLE FOODS MARKETS, INC. via CONSTANTINE CANNON, LLP
2008 · fourth_quarter · RR
Issues affecting merger enforcement policies in industry.
Issues affecting merger enforcement policies in industry.
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2008 · third_quarter · Q3
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2008 · second_quarter · 2A
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Filing targets: SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2008 · third_quarter · Q3
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2008 · second_quarter · 2A
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Filing targets: SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2008 · second_quarter · Q2
Issues pertinent and relevant to the retail industry.
Issues relating to payment systems.
Filing targets: Federal Bureau of Investigation (FBI), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2008 · second_quarter · Q2
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Physician Payments Sunshine Act of 2007, S. 2029 - concerning marketing codes for interactions with healthcare professionals. Safeguarding American's Pharmaceuticals Act, H.R. 5839 - concerning counterfeit medicines.
Filing targets: SENATE
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2008 · second_quarter · Q2
Issues relating to attorney-client privilege.
Filing targets: SENATE
CIRCUIT CITY STORES INC via CONSTANTINE CANNON, LLP
2008 · first_quarter · 1A
Advocacy of client position on issues important to consumer electronics retailers, including the transition to digital television and electronics recycling.
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2008 · first_quarter · Q1
Issues relating to attorney-client privilege.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2008 · first_quarter · Q1
All issues pertinent and relevant to the retail industry.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2008 · first_quarter · 1A
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2008 · first_quarter · Q1
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Economic Council (NEC), SENATE, Treasury, Dept of
CIRCUIT CITY STORES INC via CONSTANTINE CANNON, LLP
2008 · first_quarter · Q1
Advocacy of client position on issues important to consumer electronics retailers, including the transition to digital television and electronics recycling.
AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13) via CONSTANTINE CANNON, LLP
2008 · first_quarter · RR
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies
ASSOCIATION OF CORPORATE COUNSEL via CONSTANTINE CANNON, LLP
2007 · year_end · YY
Issues relating to attorney-client privilege.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOOD MARKETING INSTITUTE via CONSTANTINE CANNON, LLP
2007 · year_end · YY
Issues relating to payment systems.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2007 · year_end · YY
Organized retail crime issues affecting retailers.
Filing targets: Federal Bureau of Investigation (FBI), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE, White House Office
INSURANCE SERVICES OFFICE (ISO) via CONSTANTINE CANNON, LLP
2007 · year_end · YY
Legislation affecting the insurance industry.
Filing targets: SENATE
PURDUE PHARMA L P via CONSTANTINE CANNON, LLP
2007 · year_end · YY
OxyContin Criminal Settlement issue.
Filing targets: SENATE
CIRCUIT CITY STORES INC via CONSTANTINE CANNON, LLP
2007 · year_end · YY
Advocacy of client position on issues important to consumer electronics retailers, including the transition to digital television and electronics recycling.
RETAIL INDUSTRY LEADERS ASSOCIATION via CONSTANTINE CANNON, LLP
2007 · mid_year · MM
Organized retail crime issues affecting retailers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROOKSIDE CAPITAL PARTNERS/HILLSIDE CAPITAL INCORPORATED via CONSTANTINE CANNON, LLP
2007 · mid_year · MM
Pension Funding Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies
Intellectual property, FDA, Medicare/Medicaid, R&D, and tax issues affecting pharmaceutical companies